JAG1 and cancer: Recent studies have shown that HSPCs can stimulate angiogenesis through high-level secretion of VEFG; upregulation of Jagged-1, a major ligand of Notch signaling in cancer cells; and regulation of the epithelial–mesenchymal transition (EMT), promoting a metastatic phenotype and cancer progression [55,56].